Trial Profile
Prospective, Non-Interventional, Multi-Centre Trial of recombinant human thrombopoietin (rhTPO) in the Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Lymphoma and lung cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Thrombopoietin (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 29 Apr 2016 New trial record